Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

2(29%)

Results Posted

20%(1 trials)

Phase Distribution

Ph not_applicable

71%

Ph phase_2

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

2(28.6%)

N/ANon-phased studies

5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(5)

Detailed Status

Completed5

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (28.6%)

N/A5 (71.4%)

Trials by Status

completed571%

recruiting229%

Recent Activity

2 active trials

Showing 5 of 7

recruitingphase_2

Impact on Quality of Life with Pulmonary RehAbilitation After Pulmonary EMBOlism: RAMBO Study

NCT05015153

completedphase_2

Capnometry-Assisted Breathing Training for COPD

NCT03457103

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT07104630Phase 2

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Recruiting

NCT06954948Not Applicable

Effect of Home-Based Pulmonary Rehabilitation

Completed

NCT05435963Not Applicable

Impact of Pulmonary Rehabilitation on Loneliness in COPD

Completed

NCT05015153Not Applicable

Impact on Quality of Life with Pulmonary RehAbilitation After Pulmonary EMBOlism: RAMBO Study

Recruiting

NCT03457103Phase 2

Capnometry-Assisted Breathing Training for COPD

Completed

NCT02426437Not Applicable

Examining Pulmonary Rehabilitation on Discharged COPD Patients

Completed

NCT02122614Not Applicable

Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation

Completed

All 7 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 7